GP1BA and autoimmune thrombocytopenic purpura: Oseltamivir, as a viral neuraminidase inhibitor, has been shown to significantly increase platelet counts in a mouse model of anti-GPIba-mediated ITP by inhibiting platelet desialylation (22).